On November 2nd, Gong Hongjia, Chairman of Jiadao Capital, led his team to visit Hunan Yineng Biopharmaceutical Co., Ltd. (hereinafter referred to as “Yineng Pharmaceutical”) for inspection and exchange, aiming to conduct an in-depth exploration of the innovative practices and development potential of the modernization of traditional Chinese medicine (TCM). Dr. Yi Yaoneng, Chairman of Yineng Pharmaceutical, together with the company’s senior management team, extended a reception, and both sides held in-depth discussions on industry trends, technological innovation and cooperation opportunities.
Under the guidance of Dr. Yi Yaoneng, Chairman Gong Hongjia and his entourage visited three core areas of Yineng Pharmaceutical, namely the Experimental Center Headquarters Exhibition Hall, the Pilot-scale Workshop and the R&D Laboratory. In the exhibition hall, through immersive experiences such as interactive screens and AI TCM robots, Chairman Gong Hongjia and his team gained a detailed understanding of Yineng Pharmaceutical’s development philosophy of “serving the country and safeguarding people’s health”. They fully felt the unique charm of the integration of TCM and modern science and technology, ranging from the digital deconstruction of classic TCM prescriptions to AI-empowered precision R&D. Entering the pilot-scale workshop and R&D laboratory, the inspection team observed the entire process of TCM extraction and pharmaceutical R&D at close range, and highly recognized Yineng Pharmaceutical’s technological breakthroughs in classic TCM prescriptions and new TCM drugs.
At the forum, Dr. Yi Yaoneng extended a warm welcome to Chairman Gong Hongjia and his entourage. He elaborated on Yineng Pharmaceutical’s development history, core technological advantages and future strategic planning, and focused on sharing the company’s practices and reflections in the industrialization and digital-intelligent layout of TCM. Chairman Gong Hongjia fully affirmed Yineng Pharmaceutical’s intensive cultivation and innovative achievements in the field of TCM modernization. He stated, “Yineng Pharmaceutical has deeply integrated the wisdom of traditional Chinese medicine with modern digital-intelligent technologies, which precisely aligns with the development trend of the big health industry and boasts broad market prospects and investment value.”
This inspection has built an efficient communication bridge between the two parties and injected strong impetus into the development of Yineng Pharmaceutical. Chairman Gong Hongjia clearly pointed out the development path of “deep cultivation” and “quality-oriented production”, which reflects not only business wisdom, but also valuable industrial responsibility and vision. In the future, Yineng Pharmaceutical will always uphold the original aspiration of “empowering traditional Chinese medicine with science and technology and safeguarding health with high-quality medicines”. Taking innovation as the edge and craftsmanship as the foundation, the company will forge core products with focus and concentration, and join hands with more high-quality partners to jointly promote the modernization, industrialization and internationalization of traditional Chinese medicine, enabling traditional Chinese medicine to radiate stronger vitality in the new era.
Post time: Jan-13-2026